Factor | Complete response rate N (%) | OR (95% CI) | p-value | aOR (95% CI) | p-value | |
---|---|---|---|---|---|---|
Skin thickening | ||||||
No | 15 (62.5) | Reference | Reference | |||
Yes | 34 (40.5) | 0.41 (0.16–1.04) | 0.060 | 0.05 (0.01–0.38) | 0.004 | |
Each additional month delay at presentation | 0.97 (0.95–0.99) | 0.014 | 0.31 (0.11–0.86) | 0.023 | ||
Each additional cycle of chemotherapy | 1.42 (1.21–1.68) | <0.001 | 2.09 (1.44–3.01) | <0.001 | ||
Prior chemotherapy | ||||||
Exposed | 14 (73.7) | Reference | Reference | |||
Naive | 103 (92.0) | 4.09 (1.20–13.95) | <0.001 | 4.72 (1.25–17.78) | 0.022 |